ArticleJournal of peptide science : an official publication of the European Peptide Society2026
Serendipitous Discovery of Short Peptides Dimethylammonium Salt Promoting Neural Differentiation.
Article in Journal of peptide science : an official publication of the European Peptide Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The synthesis and in vitro neuronal growth support activity of a novel series of heptapeptides (1-19) are reported here. Structural studies of the peptide 3 (LSAVTFG.DMA) revealed an unexpected dimethylammonium (DMA) salt adduct formation localized at the C-terminal glycine residue. DOSY NMR analysis revealed the presence of two distinct species exhibiting different diffusion coefficients, allowing the differentiation between the peptide and the DMA adduct. Peptide 3 promoted neural differentiation at 100 μM concentration. To identify residues crucial for biological activity, we conducted L- and D-alanine scans with salt and nonsalt form of peptide 3, which resulted in the synthesis of 16 peptide analogs. Findings from the alanine scan revealed that the lead peptides L1A.DMA (13) and S2A.DMA (15) exhibited significant neural progenitor cells or neural stem cells (NPCs/NSCs) differentiation activity. These peptides promote neuronal survival, morphology recovery, increase cell proliferation, and preserve neuronal network integrity under OGD/R and hypoxia/R insult in an in vitro model of ischemic stroke. These results represent the first synthetic approach to new neuromodulatory peptides and deliver important structure-activity relationship (SAR) insights to guide the development of bioactive peptides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.